ArticleAmerican journal of epidemiology2014

"First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.

Shirley V Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.